Copyright © Inderes 2011 - present. All rights reserved.

Simris Group

0.08 SEK

-10.00 %

Less than 1K followers

SIMRIS B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-10.00 %
-14.74 %
+89.25 %
+89.25 %
-34.68 %
-27.35 %
-83.64 %
-86.05 %
-98.54 %

Simris Group is a biotechnology company. The company is focused on research and development of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. Simris Group was founded in 2011 and is headquartered in Hammenhög.

Read more
Market cap
109.33M SEK
Turnover
19.3K SEK
Revenue
1.62M
EBIT %
-1,830.46 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.5
2026

Interim report Q1'26

27.5
2026

General meeting '26

12.8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Want more examples? During my 25-30 year investing career, especially regarding IPOs (and even more so crowdfunding), I’ve noticed that a company that doesn’t communicate is usually a bad investment. Fortunately, I’ve only had a few grand in these, max €5k. Medicortex and Fifax are...
5/10/2023, 8:37 PM
by Eskimo68
3
Another share issue underway; they are planning (again) to list on First North. Interesting, I can’t even find information on whether the previous issue was successful and if more funding was secured from Business Finland. Maybe it was mentioned at the AGM, but I wasn’t particularly...
8/6/2024, 1:13 PM
by Eskimo68
1
Since information is so sparse, I’ll continue writing critically. Reluctantly, because scaring off potential new investors doesn’t exactly help my own stake. The fact that there is a new quick “offering” (well described, @Hysky) is worrying. If the management is competent, raising...
1/10/2023, 2:46 PM
by Eskimo68
1
I attended the 2026 annual general meeting. Nothing particularly noteworthy, essentially, they’re awaiting Nosium’s Reverse TakeOver. I expressed a dissenting opinion on the board’s “giant compensation packages,” especially considering the company’s continuous positive results . ...
3/31/2026, 11:38 AM
by Eskimo68
0
They have another share issue underway right now at a price of €1, so in that sense, the share value is theoretically increasing. Once again, information is far too scarce. If there were at least some kind of shareholder list available so we knew who has invested in the company, ...
1/24/2024, 5:16 PM
by Eskimo68
0
They managed to raise 110k€ by the end of May. That’s presumably a fairly good amount already. Now, if I only had the energy to dig into how much the company spends each month, which is of course difficult because part of it probably comes from the DoD’s pot. Then when you add “new...
6/8/2023, 5:08 PM
by Eskimo68
0
Let me add that if minority shareholders owned 20-30% of the company based on these n+1 share issues, the company would already be on a sounder footing. I couldn’t find the current ownership structure myself (though I have requested it in the past). On a sound footing, it could then...
5/10/2023, 8:41 PM
by Eskimo68
0
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.